Erdafitinib
ATC L01EN01 · 9 markets · 24 records
CA 4 records · 3 strengths
US 3 records · 3 strengths
GB 3 records · 3 strengths
SG 3 records · 3 strengths
ES 3 records · 3 strengths
TW 3 records · 3 strengths
HK 3 records · 1 strengths
Records without a stated strength · 1 BALVERSA
MX 1 records · 1 strengths
Records without a stated strength · 1 BALVERSA
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 BALVERSA
| Strength / form / release | US | GB | CA | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 5 mg tablet | BALVERSA | BALVERSA | BALVERSA | BALVERSA | BALVERSA | BALVERSA 盼樂膜衣錠5毫克 | |||
| 4 mg tablet | BALVERSA | BALVERSA | BALVERSA | BALVERSA | BALVERSA | BALVERSA 盼樂膜衣錠4毫克 | |||
| 3 mg tablet | BALVERSA | BALVERSA | BALVERSA | BALVERSA | BALVERSA | BALVERSA 盼樂膜衣錠3毫克 | |||
unknown | BALVERSA | BALVERSA | |||||||
tablet | BALVERSA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in MX · HK · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX · HK · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX · HK · EU 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 MX · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.